GFT would measure whether the system prevents harm and answers for the product

The first approval is not a technology choice. It is a written scope determination naming the contracting entities, production sites, product family, intended use, sales route, consignee, importer and other relevant economic operators. The reviewer should also identify the destination countries and the party making each public claim. A factory cannot select the correct evidence population while these questions remain open. Nor can it distinguish a direct legal duty from a buyer request merely by reading the buyer's questionnaire.

The route decision should produce a role map rather than a generic statement of EU readiness. For each obligation or request, record the duty holder, the operational contributor, the evidence reviewer, the payer and the person authorised to act. Legal advice, investment approval, product release and publication authority need separate decision rights. One sponsor may coordinate the register, but that sponsor should not silently acquire every approval. Roles are named by function here because no GFT staffing or client organisation is assumed.

A current-law register then converts the route into dated rows. Each row needs the instrument, provision, product or entity scope, legal status, application conditions, relevant national implementation, source version and next review trigger. Adoption, publication, entry into force, transposition and application are different states. The Commission's acts register, as opened for this research, lists the July 2026 simplified reporting and voluntary value-chain standards as not in force until Official Journal publication. A roadmap should preserve that qualification rather than treating adoption as immediate application.[S04]

The same discipline applies to rules already described as applying. The Commission states that the consumer-law changes entered application on 27 September 2026, while the PPWR began applying on a phased basis from 12 August 2026. Those dates do not make every provision identical in scope or make every supplier the duty holder. The register must still identify the actual claim, packaging, role and destination.[S18][S20]

Corporate due diligence needs a separate row from product evidence. The Commission describes the amended CSDDD as a duty for very large companies within its scope, with Member States applying the principal transposition measures from 26 July 2029 and the Article 16 reporting measures for financial years starting on or after 1 January 2030. These are not universal African factory deadlines. They are review points for the buyer relationship and any entity that may itself be in scope.[S02][S35]

The adopted amending text also shows why purpose belongs in every register row. Its reporting protection for protected undertakings concerns information requested for sustainability reporting, and its CSDDD information safeguards answer a different purpose. Product-safety and chemical evidence cannot be dismissed by attaching a general reporting label to the request. The route reviewer should record why the information is needed before selecting a response or a refusal.[S35]

Approval requires a short exception log. Record provisions not checked, national transposition not verified, uncertain product classification, unavailable buyer terms and any evidence that could not be retrieved. An exclusion should state its reasoning and its reopening trigger. A register that says only compliant or not applicable hides the work that remains. A register that preserves conditional and unresolved states gives management a decision it can safely revisit.

The first operating gate protects people and the product before it optimises administration. Worker protection begins with safe recruitment and grievance routes, the ability to escalate beyond the production hierarchy, and a remedy process that can be checked with the affected person. The ILO and IOE handbook uses the forced-labour definition and its indicators to help companies identify and assess risks in practice. An indicator should start enquiry and protective action, not become an unsupported accusation or a line item deferred until the order closes.[S09]

Recruitment and remedy records should therefore sit outside the shipment deadline's control. A supervisor under pressure to dispatch should not be the only person able to close a concern about withheld documents, debt or coercion. The proposed gate asks whether the affected person is safe, whether immediate action has an independent owner, whether evidence is restricted to those who need it and whether the agreed remedy has been confirmed. The gate remains open when administrative closure is not matched by the person's experience.

Product evidence forms the other side of the same release decision. EU guidance states that every textile product marketed in the EU must be labelled or marked to show fibre composition, subject to the applicable scope and business-to-business provisions. The bill of materials, approved composition, language version and printed label therefore need a traceable relationship to the product being released.[S17] A claim approved for an earlier material specification should not be carried across an unreviewed change.

Chemical evidence needs its own product-specific test. The Commission explains that REACH restrictions on placing substances on the market apply to domestic production and imports, and identifies restrictions for clothing, textiles and footwear in Annex XVII entry 72. That establishes the need to examine the actual article and restriction. It does not allow a generic supplier declaration to replace the operative limits, method, sample identity or batch relationship.[S16]

Safety continues after production. EU guidance states that products sold in the EU must be safe regardless of where they were made, and that manufacturers and other businesses linked to distribution or sale must act if they find an unsafe product. The release file should therefore connect design and test evidence to complaints, corrective action, withdrawal or recall routes where applicable. A sustainability label or a completed buyer portal does not answer that product-safety question.[S33]

Exhibit 60 shows why the release decision should not become a single maturity score. The vertical dimension is the consequence of leaving an issue unresolved, not a measured legal risk. The horizontal dimension is the degree to which the issue sits in routine evidence administration or requires operational change. A duplicate schema can be inconvenient without being decisive. Unresolved chemical evidence or a worker-protection failure requires containment or protection regardless of the average completeness score.

The map is not permission to rank one person's harm against another product failure. It is a rule against compensation between unlike failures. Missing reporting information may justify clarification and rework. A label mismatch may require correction and a new approval. An unresolved safety, chemical or worker-protection condition may require a hold, urgent action or specialist escalation. Each state needs its own decision and named authority.

A hold should be precise about its object. Identify the affected people, requirement, input lots, batches, claims and shipments. Record what is known, what is missing, who may release the hold and what evidence would change the decision. Do not describe an internal precaution as an authority prohibition. Conversely, do not wait for an external authority before taking a protective step that the supplier can already see is necessary.

The gate also needs a change trigger. A new dye recipe, trim supplier, production site, subcontractor, intended use or consumer claim can change the evidence question. A responsible reviewer should determine whether the earlier evidence remains valid before the changed product enters the eligible release population. A form marked complete after the change is not evidence that the review occurred before it.

The pilot should be small enough to inspect and real enough to expose the work. Select one product family, one defined sales route and a limited set of applicable requirements after the scope review. The product choice, order volume and acceptance criteria must come from the actual opportunity. This chapter does not invent them. The useful unit is not a generic factory transformation but a controlled chain from product specification to production event, batch evidence, review, release and buyer response.

The pilot pack should contain the route-and-role statement, current-law rows, product specification, applicable label and test evidence, change history, worker-protection route, corrective-action register and a controlled response index. Each item needs an owner, period, evidence location, version and review state. Missing, disputed, corrected and not-applicable entries should remain distinguishable. A blank field must not become a zero incident count or a declaration that every upstream input conforms.

Reuse begins with a canonical answer rather than a copied attachment. The answer should retain its definition, source boundary and effective version so that a later request can be matched to it. The Commission's VSME recommendation is intended to reduce administrative burden by making it easier for SMEs to answer sustainability-information requests from large companies and financial institutions. That supports a common response structure for its intended purpose, not a universal product file or proof that every buyer will accept the same extract.[S05]

Purpose-based triage protects the pack from request inflation. Route each question to sustainability reporting, due diligence, product safety, chemicals, commercial specification, claims or another identified purpose. Reuse only evidence with the same population, period and meaning. The adopted reporting amendment gives protected undertakings a right, subject to its conditions, to decline information beyond the voluntary standards for specified reporting requests. It does not create a blanket refusal for necessary product or investigation evidence.[S35]

A retrieval test should use a real question and a controlled clock. Record when the request becomes sufficiently clear to answer, when the reviewer receives the pack and how much active work was needed for collection, translation, checking, approval and portal entry. Keep recipient waiting time separate from supplier work. A portal acknowledgement is not buyer acceptance, and a file found quickly is not necessarily the right file.

Corrective action belongs inside the pilot rather than after its evaluation. If the pack lacks a batch link, assign the repair and repeat the retrieval. If a worker-related record exposes unnecessary identity information, revise access before circulating the pack again. If a product test does not cover the changed specification, hold the relevant release and establish the evidence required. Scaling should be conditional on these repeated decisions working, not on the first demonstration looking complete.

The scale decision needs evidence of review as well as evidence of completion. A qualified legal reviewer may need to confirm an unresolved scope point. The buyer may need to confirm that a controlled extract answers its stated purpose. Operations may need to demonstrate that the release gate holds when production is busy. Worker-protection actions need appropriate confirmation and recurrence review. None of these is interchangeable with a draft pack or a successful upload.